Skip to main navigation Skip to search Skip to main content

Target directed enediyne prodrugs: hER and AhR degradation by a synthetic oxo-enediyne

  • Graham B. Jones
  • , Michael W. Kilgore
  • , Richard S. Pollenz
  • , Aiwen Li
  • , Jude E. Mathews
  • , Justin M. Wright
  • , Robert S. Huber
  • , Patricia L. Tate
  • , Thomas L. Price
  • , Robert P. Sticca

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

An efficient route to oxo-enediynes is presented. A simple oxo-enediyne has been synthesized, which cyclizes to give an isochroman. The agent shows cytotoxicity for ER rich breast cancer cells and a model for its mode of action is proposed.

Original languageEnglish
Pages (from-to)1971-1976
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume6
Issue number16
DOIs
StatePublished - Aug 20 1996

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Target directed enediyne prodrugs: hER and AhR degradation by a synthetic oxo-enediyne'. Together they form a unique fingerprint.

Cite this